BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma.

BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma.

Item
http://www.wikidata.org/entity/Q38771627
BRD4 inhibition suppresses cell growth, migration and invasion of salivary adenoid cystic carcinoma.Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de-differentiated state.BET inhibitors: a novel epigenetic approach.The role of phenotypic plasticity in the escape of cancer cells from targeted therapy.Critical role of reactive oxygen species (ROS) for synergistic enhancement of apoptosis by vemurafenib and the potassium channel inhibitor TRAM-34 in melanoma cells.Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.Oridonin synergistically enhances JQ1-triggered apoptosis in hepatocellular cancer cells through mitochondrial pathway.Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma.ERK5 is activated by oncogenic BRAF and promotes melanoma growth.Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors
P2860

BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma.

Item
http://www.wikidata.org/entity/Q38771627
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma.
@en
type
label
BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma.
@en
prefLabel
BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932